Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Фев. 9, 2024
Abstract
Postural
Orthostatic
Tachycardia
Syndrome
(POTS)
reflects
an
autonomic
dysfunction,
which
can
occur
as
a
complication
to
COVID-19.
Our
aim
was
examine
gastrointestinal
symptoms
and
gut
microbiota
composition
in
patients
with
POTS
post-acute
COVID-19
syndrome
(PACS),
compared
controls.
(
n
=
27),
PACS
32)
controls
39)
delivered
fecal
samples
completed
4-day
food
diary,
irritable
bowel
syndrome-severity
scoring
system
(IBS-SSS),
visual
analog
scale
for
IBS
(VAS-IBS).
A
total
of
98
DNA
aliquots
were
sequenced
average
depth
28.3
million
(M)
read
pairs
(Illumina
2
×
150
PE)
per
sample.
Diversity
taxonomic
levels
the
microbiome,
well
functional
abundances
calculated
groups,
then
There
several
differences
between
controls,
whereas
only
abundance
Ascomycota
Firmicutes
differed
The
clinical
variables
IBS-SSS,
fatigue,
bloating
flatulence
significantly
correlated
multiple
individual
taxa
abundances,
alpha
diversity,
abundances.
We
conclude
that
POTS,
less
extent
PACS,
are
associated
diversity
at
levels.
Clinical
both
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Март 8, 2023
The
gut
microbiota
plays
a
crucial
role
in
human
health
and
disease.
Gut
dysbiosis
is
known
to
be
associated
with
increased
susceptibility
respiratory
diseases
modifications
the
immune
response
homeostasis
of
lungs
(the
so-called
gut-lung
axis).
Furthermore,
recent
studies
have
highlighted
possible
neurological
disturbances,
introducing
notion
"gut-brain
axis."
During
last
2
years,
several
described
presence
during
coronavirus
disease
2019
(COVID-19)
its
relationship
severity,
SARS-CoV-2
gastrointestinal
replication,
inflammation.
Moreover,
persistence
after
resolution
may
linked
long-COVID
syndrome
particularly
manifestations.
We
reviewed
evidence
on
association
between
COVID-19,
investigating
epidemiologic
confounding
factors
like
age,
location,
sex,
sample
size,
severity
disease,
comorbidities,
therapy,
vaccination
status
airway
microbial
selected
both
COVID-19
long-COVID.
we
analyzed
strictly
related
microbiota,
specifically
diet
investigation
previous
use
antibiotics/probiotics,
methodology
used
study
(α-
β-diversity
parameters
relative
abundance
tools).
Of
note,
only
few
focused
longitudinal
analyses,
especially
for
long-term
observation
Lastly,
there
lack
knowledge
regarding
transplantation
other
therapeutic
approaches
their
impact
progression
severity.
Preliminary
data
seem
suggest
that
might
play
symptoms.
Indeed,
development
interpretation
these
could
important
implications
future
preventive
strategies.
Biomedicines,
Год журнала:
2021,
Номер
9(10), С. 1340 - 1340
Опубликована: Сен. 28, 2021
Lactobacilli
and
bifidobacteria
are
an
important
part
of
human
gut
microbiota.
Among
numerous
benefits,
their
antioxidant
properties
attracting
more
attention.
Multiple
in
vivo
vitro
studies
have
demonstrated
that
lactobacilli
bifidobacteria,
along
with
cellular
components,
possess
excellent
capacity,
which
provides
a
certain
degree
protection
to
the
body
against
diseases
associated
oxidative
stress.
Recently,
begun
be
considered
as
new
source
natural
antioxidants.
This
review
summarizes
current
state
research
on
various
bifidobacteria.
Special
emphasis
is
given
mechanisms
activity
these
bacteria
microbiota,
involve
bacterial
cell
components
metabolites.
also
dedicated
genes
involved
strains
indicators
potential
Identification
biomarkers
microbiota
great
importance
both
for
creating
diagnostic
systems
assessing
stress
choosing
strategies
aimed
at
restoring
normal
functioning
and,
through
it,
health.
In
this
review,
practical
application
probiotic
proven
prevent
considered.
Communications Biology,
Год журнала:
2021,
Номер
4(1)
Опубликована: Апрель 13, 2021
The
relationship
between
gut
microbes
and
COVID-19
or
H1N1
infections
is
not
fully
understood.
Here,
we
compared
the
mycobiota
of
67
patients,
35
H1N1-infected
patients
48
healthy
controls
(HCs)
using
internal
transcribed
spacer
(ITS)
3-ITS4
sequencing
analysed
their
associations
with
clinical
features
bacterial
microbiota.
Compared
to
HCs,
fungal
burden
was
higher.
Fungal
dysbiosis
in
both
mainly
characterized
by
depletion
fungi
such
as
Aspergillus
Penicillium,
but
several
fungi,
including
Candida
glabrata,
were
enriched
patients.
profiles
mild
severe
symptoms
similar.
Hospitalization
had
no
apparent
additional
effects.
In
Mucoromycota
positively
correlated
Fusicatenibacter,
niger
diarrhoea,
Penicillium
citrinum
negatively
C-reactive
protein
(CRP).
penicilloides
Lachnospiraceae
members,
CRP,
procalcitonin.
Therefore,
occurs
does
improve
until
are
discharged
longer
require
medical
attention.
Foods,
Год журнала:
2021,
Номер
10(6), С. 1297 - 1297
Опубликована: Июнь 4, 2021
Growing
interest
in
the
development
of
innovative
functional
products
as
ideal
carriers
for
synbiotics,
e.g.,
nutrient
bars,
yogurt,
chocolate,
juice,
ice
cream,
and
cheese,
to
ensure
daily
intake
probiotics
prebiotics,
which
are
needed
maintain
a
healthy
gut
microbiota
overall
well-being,
is
undeniable
inevitable.
This
review
focuses
on
modern
approaches
that
currently
being
developed
modulate
microbiota,
with
an
emphasis
health
benefits
mediated
by
co-encapsulated
synbiotics
immobilized
probiotics.
The
impact
processing,
storage,
simulated
gastrointestinal
conditions
viability
bioactivity
together
prebiotics
such
omega-3
polyunsaturated
fatty
acids,
phytochemicals,
dietary
fibers
using
various
delivery
systems
considered.
Despite
proven
biological
properties
research
this
area
needs
be
focused
proper
selection
probiotic
strains,
their
prebiotic
counterparts,
avoid
suppression
synergistic
or
complementary
effect
human
health.
Future
directions
should
lead
food
containing
stable
tailored
different
age
groups
specifically
designed
fulfill
adjuvant
therapy.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2022,
Номер
12
Опубликована: Март 4, 2022
The
Coronavirus
Disease
2019
(COVID-19)
pandemic
caused
by
Severe
Acute
Respiratory
2
(SARS-CoV-2)
emerged
in
late
December
2019.
Considering
the
important
role
of
gut
microbiota
maturation,
regulation,
and
induction
immune
system
subsequent
inflammatory
processes,
it
seems
that
evaluating
composition
COVID-19
patients
compared
with
healthy
individuals
may
have
potential
value
as
a
diagnostic
and/or
prognostic
biomarker
for
disease.
Also,
therapeutic
interventions
affecting
microbial
flora
open
new
horizons
treatment
accelerating
their
recovery.
Annals of Intensive Care,
Год журнала:
2022,
Номер
12(1)
Опубликована: Янв. 5, 2022
Abstract
The
composition
of
the
gut
microbiota
is
highly
dynamic
and
changes
according
to
various
conditions.
mainly
includes
difficult-to-cultivate
anaerobic
bacteria,
hence
knowledge
about
its
has
significantly
arisen
from
culture-independent
methods
based
on
next-generation
sequencing
(NGS)
such
as
16S
profiling
shotgun
metagenomics.
patients
hospitalized
in
intensive
care
units
(ICU)
undergoes
many
alterations
because
critical
illness,
antibiotics,
other
ICU-specific
medications.
It
then
characterized
by
lower
richness
diversity,
dominated
opportunistic
pathogens
Clostridioides
difficile
multidrug-resistant
bacteria.
These
are
associated
with
an
increased
risk
infectious
complications
or
death.
Specifically,
at
time
writing,
it
appears
possible
identify
distinct
patterns
severity
infectivity
COVID-19
patients,
paving
way
for
potential
use
dysbiosis
markers
predict
patient
outcomes.
Correcting
disturbances
avoid
their
consequences
now
possible.
Fecal
transplantation
recommended
recurrent
C.
infections
microbiota-protecting
treatments
antibiotic
inactivators
currently
being
developed.
growing
interest
microbiota-associated
therapies
suggests
that
control
could
be
a
key
factor
management
critically
ill
patients.
present
narrative
review
aims
provide
synthetic
overview
microbiota,
healthy
individuals
After
introduction
different
techniques
used
studying
we
determinants
involved
alteration
ICU
latter’s
consequences.
Last,
assess
means
prevent
correct
alteration.
Microorganisms,
Год журнала:
2024,
Номер
12(1), С. 131 - 131
Опубликована: Янв. 9, 2024
COVID-19
has
been
associated
with
having
a
negative
impact
on
patients’
gut
microbiome
during
both
active
disease
and
in
the
post-acute
phase.
In
acute
COVID-19,
rapid
alteration
of
composition
was
observed,
showing
one
side
reduction
beneficial
symbionts
(e.g.,
Roseburia,
Lachnospiraceae)
other
an
increase
opportunistic
pathogens
such
as
Enterococcus
Proteobacteria.
Alpha
diversity
tends
to
decrease,
especially
initially
symptom
onset
hospital
admission.
Although
clinical
recovery
appears
align
improved
homeostasis,
this
process
could
take
several
weeks,
even
mild
infections.
Moreover,
patients
syndrome
showed
changes
composition,
specific
signatures
decreased
respiratory
function
up
12
months
following
disease.
Potential
treatments,
probiotic-based
therapy,
are
under
investigation.
Open
questions
remain
possibility
use
data
predict
progression
potential
confounders
that
may
impair
result
interpretation
concomitant
therapies
phase;
reinfection,
vaccines,
occurrence
novel
conditions
or
diseases
syndrome).
Understanding
relationships
between
dynamics
contribute
better
understanding
post-COVID
pathogenesis
inform
personalized
treatment
can
affect
targets
markers.